Arctic Bioscience AS (ABS.OL)

NOK 4.6

(-12.21%)

EBITDA Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual EBITDA in 2023 was -37.78 Million NOK , down -42.62% from previous year.
  • Arctic Bioscience AS's latest quarterly EBITDA in 2024 Q2 was -11.36 Million NOK , down 0.0% from previous quarter.
  • Arctic Bioscience AS reported an annual EBITDA of -30.28 Million NOK in 2022, up 23.73% from previous year.
  • Arctic Bioscience AS reported an annual EBITDA of -37.94 Million NOK in 2021, down -99.38% from previous year.
  • Arctic Bioscience AS reported a quarterly EBITDA of -11.36 Million NOK for 2024 Q1, up 7.06% from previous quarter.
  • Arctic Bioscience AS reported a quarterly EBITDA of -12.23 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Arctic Bioscience AS (2023 - 2018)

Created with Highcharts 11.1.0YearsEBITDA20182018.520192019.520202020.520212021.520222022.52023-40000000 NOK-30000000 NOK-20000000 NOK-10000000 NOK0 NOK

Historical Annual EBITDA of Arctic Bioscience AS (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -37.78 Million NOK -42.62%
2022 -30.28 Million NOK 23.73%
2021 -37.94 Million NOK -99.38%
2020 -20.88 Million NOK -716.16%
2019 -2.32 Million NOK -267.7%
2018 -663.82 Thousand NOK 0.0%

Peer EBITDA Comparison of Arctic Bioscience AS

Name EBITDA EBITDA Difference
Aqua Bio Technology ASA -16.56 Million NOK -128.065%
ArcticZymes Technologies ASA 31.64 Million NOK 219.405%
BerGenBio ASA -191.8 Million NOK 80.3%
Hofseth BioCare ASA -70.6 Million NOK 46.482%
PCI Biotech Holding ASA -22.22 Million NOK -70.032%
Thor Medical ASA -6.82 Million NOK -453.295%
Ultimovacs ASA -214.85 Million NOK 82.414%